TY  - RPRT
TI  - First-generation EGFR-TKI plus chemotherapy versus EGFR-TKI alone as first-line treatment in advanced NSCLC with EGFR activating mutation: a systematic review and meta-analysis of randomized controlled trials
AU  - Wu, Q.
AU  - Luo, W.
AU  - Li, W.
AU  - Wang, T.
AU  - Huang, L.
AU  - Xu, F.
PY  - 2020
DO  - 10.1101/2020.04.17.046409
UR  - https://www.biorxiv.org/content/10.1101/2020.04.17.046409v1
ID  - 10.1101/2020.04.17.046409
ER  -